Multiple sclerosis (MS) rates in the U.S. have nearly doubled over the past decade, making it a leading cause of nontraumatic functional impairment in young ad…

Multiple SclerosisPathologic ProcessesDemyelinating Autoimmune Diseases, CNS+5 more

~Estimated

~$10 – $6,250

University of Texas at AustinNCT07759115

Phase 1

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gr…

Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more

~Estimated

~$10 – $8,750

Arcellx, Inc.NCT06626919